A potent hybrid of two anticancer natural products has been designed and synthesised by UK chemists. Developing analogues of natural products with improved biological activity is an area of great current interest. Ian Paterson and colleagues atthe University of Cambridge have now made a natural product analogue with anticancer activity using a combination of rational design and state-of-the-art synthesis.
展开▼
